Skip to main content
. 2022 Sep 19;18(9):e1010782. doi: 10.1371/journal.ppat.1010782

Fig 4. Detection of neutralizing antibody activity against SARS-CoV-2 variants.

Fig 4

IgY-control and IgY-RBD antibody titers were measured against 2019-nCoV/USA-WA1/2020 (WT), hCoV-19/USA/MD-HP05647/2021 (Delta) or hCoV19/EHC_C19_2811C (Omicron) in Vero-ACE2/TMPRSS2 cells by plaque reduction neutralization assay. Antibody titers are determined by the highest IgY antibodies dilution that result in a 50% reduction in the number of plaques. LOD: limit of detection, <1:20.